.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Max Healthcare Institute recently announced a significant move in the Indian healthcare landscape. Specifically, the company signed a definitive agreement for the Max Healthcare acquisition of a majority stake in Kalinga Hospital. This strategic entry into Bhubaneswar marks a major milestone for the group. Consequently, the deal involves acquiring a 58.4% stake for approximately ₹300 crore. Since the hospital is a 250-bed NABH accredited facility, it offers a strong operational base for future growth.
Notably, the acquisition targets Kalinga Hospital, a premier institution located in Odisha. This facility sits on a prime 10-acre land parcel in the capital city. Furthermore, the hospital provides advanced care across neurology, cardiology, and orthopaedics. It also excels in gastroenterology, renal sciences, and oncology. Additionally, the site houses an in-house diagnostics unit. This unit includes high-end technology like a 128-slice CT scanner and a 1.5T MRI. Therefore, the infrastructure supports complex medical procedures and comprehensive patient care in Eastern India.
Meanwhile, Max Healthcare continues its aggressive push into non-metro markets across India. The group recently surpassed a market capitalization of ₹1 lakh crore. Moreover, the leadership identifies Bhubaneswar as an extremely attractive market with significant brownfield potential. This move follows another recent agreement to develop a 450-bed hospital in Pune. Specifically, the group is tapping into both greenfield and brownfield opportunities to scale its operations. Such expansions aim to improve healthcare access in emerging urban centers. Consequently, the financial performance remains strong with a reported revenue of ₹2,608 crore in the recent December quarter.
Q1: What is the size and accreditation of Kalinga Hospital?
Kalinga Hospital is a 250-bed facility that holds a prestigious NABH accreditation and sits on 10 acres of land.
Q2: What is the total equity value of the Max Healthcare acquisition?
The acquisition of the 58.4% stake in the hospital reaches an equity value of ₹300 crore.
Q3: Does the hospital have advanced diagnostic facilities?
Yes, the hospital operates an in-house diagnostics unit equipped with a 128-slice CT scanner, a 1.5T MRI, and a Cath Lab.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Max Healthcare acquires a 58.4% stake in Bhubaneswar's Kalinga Hospital for ₹300 crore, signaling a major expansion into Odisha’s growing healthcare market....
6 months ago
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today
Recent clinical studies reveal maternal autoantibodies targeting IL-1RA as potential triggers for preterm labor, opening avenues for targeted cytokine therapies. Concurrently, new perioperative findings show inhaled cannabis increases propofol requirements during upper endoscopy compared to oral edible consumption.
Today
In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
